Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $98.49 billion. The enterprise value is $122.24 billion.
Important Dates
The next confirmed earnings date is Tuesday, April 22, 2025, before market open.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | Mar 10, 2025 |
Share Statistics
Elevance Health has 226.39 million shares outstanding. The number of shares has decreased by -1.90% in one year.
| Current Share Class | 226.39M |
| Shares Outstanding | 226.39M |
| Shares Change (YoY) | -1.90% |
| Shares Change (QoQ) | -0.86% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 93.78% |
| Float | 225.89M |
Valuation Ratios
The trailing PE ratio is 16.94 and the forward PE ratio is 12.72. Elevance Health's PEG ratio is 1.62.
| PE Ratio | 16.94 |
| Forward PE | 12.72 |
| PS Ratio | 0.57 |
| Forward PS | 0.51 |
| PB Ratio | 2.40 |
| P/TBV Ratio | 104.33 |
| P/FCF Ratio | 21.64 |
| P/OCF Ratio | 16.96 |
| PEG Ratio | 1.62 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.40, with an EV/FCF ratio of 26.85.
| EV / Earnings | 20.44 |
| EV / Sales | 0.69 |
| EV / EBITDA | 12.40 |
| EV / EBIT | 13.29 |
| EV / FCF | 26.85 |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.45 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 3.19 |
| Debt / FCF | 7.04 |
| Interest Coverage | 7.76 |
Financial Efficiency
Return on equity (ROE) is 14.77% and return on invested capital (ROIC) is 8.28%.
| Return on Equity (ROE) | 14.77% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 8.28% |
| Return on Capital Employed (ROCE) | 12.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.93 billion in taxes.
| Income Tax | 1.93B |
| Effective Tax Rate | 24.46% |
Stock Price Statistics
The stock price has decreased by -13.01% in the last 52 weeks. The beta is 0.78, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -13.01% |
| 50-Day Moving Average | 413.93 |
| 200-Day Moving Average | 451.41 |
| Relative Strength Index (RSI) | 54.72 |
| Average Volume (20 Days) | 1,804,272 |
Short Selling Information
The latest short interest is 2.75 million, so 1.21% of the outstanding shares have been sold short.
| Short Interest | 2.75M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 1.21% |
| Short % of Float | 1.22% |
| Short Ratio (days to cover) | 1.69 |
Income Statement
In the last 12 months, Elevance Health had revenue of $176.81 billion and earned $5.98 billion in profits. Earnings per share was $25.68.
| Revenue | 176.81B |
| Gross Profit | 49.24B |
| Operating Income | 9.20B |
| Pretax Income | n/a |
| Net Income | 5.98B |
| EBITDA | 9.86B |
| EBIT | 9.20B |
| Earnings Per Share (EPS) | $25.68 |
Full Income StatementBalance Sheet
The company has $34.68 billion in cash and $32.04 billion in debt, giving a net cash position of -$23.76 billion or -$104.93 per share.
| Cash & Cash Equivalents | 34.68B |
| Total Debt | 32.04B |
| Net Cash | -23.76B |
| Net Cash Per Share | -$104.93 |
| Equity (Book Value) | 41.43B |
| Book Value Per Share | 181.62 |
| Working Capital | 18.36B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.81 billion and capital expenditures -$1.26 billion, giving a free cash flow of $4.55 billion.
| Operating Cash Flow | 5.81B |
| Capital Expenditures | -1.26B |
| Free Cash Flow | 4.55B |
| FCF Per Share | $20.11 |
Full Cash Flow StatementMargins
Gross margin is 27.85%, with operating and profit margins of 5.20% and 3.38%.
| Gross Margin | 27.85% |
| Operating Margin | 5.20% |
| Pretax Margin | 4.47% |
| Profit Margin | 3.38% |
| EBITDA Margin | 5.57% |
| EBIT Margin | 5.20% |
| FCF Margin | 2.57% |
Dividends & Yields
This stock pays an annual dividend of $6.84, which amounts to a dividend yield of 1.57%.
| Dividend Per Share | $6.84 |
| Dividend Yield | 1.57% |
| Dividend Growth (YoY) | 8.73% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 26.64% |
| Buyback Yield | 1.90% |
| Shareholder Yield | 3.47% |
| Earnings Yield | 6.07% |
| FCF Yield | 4.62% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $524.40, which is 20.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $524.40 |
| Price Target Difference | 20.54% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 18.12% |
Stock ForecastsStock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |